SOUTH KOREA · OPENDART
CELL BIOTECH CO ., LTD
쎌바이오텍 · 049960 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insiders' buying price vs the latest close
Insiders paid 12,841.27 KRW a share on average (6 purchase lines, 1 buyer, 2025-11-19 – 2025-11-28). The close on 2026-10-16 was 17.6% above that price.
The latest purchase (2025-11-28) was at 13,259.00 KRW; the close was 13.9% above that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025-11-28 | Yoon Yeong-ok | Director | Bought on the exchange | 16,261 | ₩13,259 | ₩215.6M | DART ↗ |
| 2025-11-25 | Yoon Yeong-ok | Director | Bought on the exchange | 15,787 | ₩12,845 | ₩202.8M | DART ↗ |
| 2025-11-24 | Yoon Yeong-ok | Director | Bought on the exchange | 18,200 | ₩12,789 | ₩232.8M | DART ↗ |
| 2025-11-21 | Yoon Yeong-ok | Director | Bought on the exchange | 4,200 | ₩12,365 | ₩51.9M | DART ↗ |
| 2025-11-20 | Yoon Yeong-ok | Director | Bought on the exchange | 3,995 | ₩12,203 | ₩48.8M | DART ↗ |
| 2025-11-19 | Yoon Yeong-ok | Director | Bought on the exchange | 1,557 | ₩11,974 | ₩18.6M | DART ↗ |
Other changes in holdings · 3
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.